Pharma News

Metabolic syndrome increases a person’s risk for diabetes, heart disease, and stroke, and includes conditions such as obesity, high blood pressure and high blood sugar. In a recent mouse-model study, published in Cell Metabolism, researchers at University Hospitals (UH), Harrington Discovery Institute at UH, and Case Western Reserve University have furthered their progress to develop a drug to treat metabolic syndrome by identifying a receptor that controls appetite and body weight.

The SARS-CoV-2 Omicron BA.1 sublineage has been supplanted in many countries by the BA.2 sublineage. Although Omicron is responsible for less severe forms in the general population, immunocompromised people are still at higher risk of developing severe forms of COVID-19. Several monoclonal antibodies are currently available in clinical practice as a preventive treatment for these patients.

Union Minister of State (Independent Charge) Science and Technology; Minister of State (Independent Charge) Earth Sciences; MoS PMO, Personnel, Public Grievances, Pensions, Atomic Energy and Space, Dr Jitendra Singh said that , the Ministry of Home Affairs (MHA), has approved projects for strengthening DNA analysis, cyber-forensics and related facilities in 23 States/UTs under Nirbhaya Fund Scheme.

The largest ever genetic study of schizophrenia has identified large numbers of specific genes that could play important roles in the psychiatric disorder.

A group of hundreds of researchers across 45 countries analysed DNA from 76,755 people with schizophrenia and 243,649 without it to better understand the genes and biological processes underpinning the condition.

Scientists have published the first complete, gapless sequence of a human genome, two decades after the Human Genome Project produced the first draft human genome sequence. According to researchers, having a complete, gap-free sequence of the roughly 3 billion bases in our DNA is critical for understanding the full spectrum of human genomic variation and for understanding the genetic contributions to certain diseases.

Rhizen Pharmaceuticals AG, a Switzerland-based privately held, clinical-stage oncology & inflammation-focussed biopharmaceutical company, announced the release of data on its differentiated next-generation clinical-stage PARP (Poly ADP-Ribose Polymerase) and DHODH (DiHydro Orotate DeHydrogenase) inhibitor programs at the American Association for Cancer Research (AACR) 2022 Annual Meeting.

The three departments functioning under the Ministry of Science and Technology - Department of Science and Technology (DST), Department of Biotechnology (DBT) and Department of Scientific and Industrial Research (DSIR) represent different areas of scientific research. These three departments have supported scientific research works, research publications, technology development; and has acquired significant scientific knowledge through innovations that contribute to the overall development of the country.

In election of pharmacy council of India, Dr. Montu Patel is elected as president of PCI. Dr. Montu Patel is became the youngest president of PCI.

In Oct 2021, Dr. Montukumar Patel who is also president of Gujarat State Pharmacy council, has won the election of executive member in PCI. Dr. Montukumar Patel was elected unopposed as executive member. He was also became youngest president of Gujarat State Pharmacy Council few years back.

Novartis announced that the U.S. Food and Drug Administration (FDA) granted accelerated approval to Vijoice (alpelisib) for the treatment of adult and pediatric patients 2 years of age and older with severe manifestations of PIK3CA-Related Overgrowth Spectrum (PROS) who require systemic therapy. Vijoice is the first FDA-approved treatment for PROS, a spectrum of rare conditions characterized by overgrowths and blood vessel anomalies impacting an estimated 14 people per million.